These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 20569068)

  • 61. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles.
    Bakheit AM; Fedorova NV; Skoromets AA; Timerbaeva SL; Bhakta BB; Coxon L
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1558-61. PubMed ID: 15489387
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis.
    Baricich A; Grana E; Carda S; Santamato A; Cisari C; Invernizzi M
    J Neural Transm (Vienna); 2015 Sep; 122(9):1283-7. PubMed ID: 25724294
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
    Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
    Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
    BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
    [TBL] [Abstract][Full Text] [Related]  

  • 66. IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.
    Dabrowski E; Chambers HG; Gaebler-Spira D; Banach M; Kaňovský P; Dersch H; Althaus M; Geister TL; Heinen F
    Pediatr Neurol; 2021 Oct; 123():10-20. PubMed ID: 34339951
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
    Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
    Lee J; Yang SN
    Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668622
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-Term Enhancement of Botulinum Toxin Injections for Post-Stroke Spasticity by Use of Stretching Exercises-A Randomized Controlled Trial.
    Hwang IS; Ryu JW; Jin S; Kim SA; Kim MS
    Toxins (Basel); 2024 Jun; 16(6):. PubMed ID: 38922161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Botulinum Toxin Type A for Upper Limb Spasticity in Poststroke Patients: A Meta-analysis of Randomized Controlled Trials.
    Jia S; Liu Y; Shen L; Liang X; Xu X; Wei Y
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104682. PubMed ID: 32305277
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does botulinum toxin improve the function of the patient with spasticity after stroke?
    Cardoso E; Pedreira G; Prazeres A; Ribeiro N; Melo A
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):592-5. PubMed ID: 17876396
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
    Simpson DM; Alexander DN; O'Brien CF; Tagliati M; Aswad AS; Leon JM; Gibson J; Mordaunt JM; Monaghan EP
    Neurology; 1996 May; 46(5):1306-10. PubMed ID: 8628472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb.
    Lagalla G; Danni M; Reiter F; Ceravolo MG; Provinciali L
    Am J Phys Med Rehabil; 2000; 79(4):377-84; quiz 391-4. PubMed ID: 10892624
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Randomized, placebo-controlled trial of incobotulinumtoxina for upper-limb post-stroke spasticity.
    Elovic EP; Munin MC; Kaňovský P; Hanschmann A; Hiersemenzel R; Marciniak C
    Muscle Nerve; 2016 Mar; 53(3):415-21. PubMed ID: 26201835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?
    Santamato A; Ranieri M; Solfrizzi V; Lozupone M; Vecchio M; Daniele A; Greco A; Seripa D; Logroscino G; Panza F
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):843-6. PubMed ID: 27291256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.